TATA健康时隔逾1年半复牌 早盘股价飙升超500%

Core Viewpoint - TATA Health (01255) has resumed trading after more than 1.5 years, experiencing a significant surge of over 500% in early trading, reaching HKD 1.86 with a trading volume of HKD 6.33 million [1] Group 1 - The company announced that it has met all the resumption guidelines, which include publishing all outstanding financial results and addressing any audit revisions [1] - The group confirmed that its business is sustainable, with sufficient operational capacity and valuable assets to support its operations [1] - An independent internal control review has been conducted, demonstrating that the company has established adequate internal controls and procedures to fulfill its responsibilities under the listing rules [1]